Photo from wikipedia
We read the study by Anand et al1 on autoimmune hepatitis (AIH) presenting as acute on chronic liver failure (ACLF) and their response to corticosteroids therapy. A careful perusal of… Click to show full abstract
We read the study by Anand et al1 on autoimmune hepatitis (AIH) presenting as acute on chronic liver failure (ACLF) and their response to corticosteroids therapy. A careful perusal of AARC publications reveals that while their 2017 publication on PIRO Model for predicting AKI had 24 participating centers,2 in the present publication,1 there are only 17 centers. We would like to know the reasons for reducing the number of centers. This article is protected by copyright. All rights reserved.
Keywords:
therapy;
concerns regarding;
study;
regarding aarc;
autoimmune hepatitis
Journal Title: Hepatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Hepatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!